Huaxin Pharmaceuticals: Received 3 Drug Re-registration Approval Notifications

Hua Sen Pharmaceutical announced that the company has recently received 3 drug "Drug Re-registration Approval Notices" issued by the Chongqing Food and Drug Administration. The drugs include oyster calcium carbonate granules, cefaclor capsules, and lincomycin hydrochloride capsules. The drug approval number for oyster calcium carbonate granules is valid until May 9, 2030; the drug approval number for cefaclor capsules is valid until April 28, 2030; and the drug approval number for lincomycin hydrochloride capsules is valid until May 9, 2030.